2023 Boca Raton Regional Hospital Internal Medicine Symposium Evaluation - Day 3

Please score your agreement with or assessment of the following questions and statements by rating on a scale of 1 to 5, with 5 representing the highest level of satisfaction or agreement. *

Scoring Key: 5=Strongly Agree 4=Agree 3=Neutral 2=Disagree 1=Strongly Disagree

	5	4	3	2	1
The information and/or skills learned will enhance my professional competence or ability.	The information and/or skills learned will enhance my professional competence or ability. - 5	The information and/or skills learned will enhance my professional competence or ability. - 4	The information and/or skills learned will enhance my professional competence or ability. - 3	The information and/or skills learned will enhance my professional competence or ability. - 2	The information and/or skills learned will enhance my professional competence or ability. - 1
This activity conveyed information which will assist me in improving the health and/or treatment outcomes of of my patients.	This activity conveyed information which will assist me in improving the health and/or treatment outcomes of of my patients. - 5	This activity conveyed information which will assist me in improving the health and/or treatment outcomes of of my patients. - 4	This activity conveyed information which will assist me in improving the health and/or treatment outcomes of of my patients. - 3	This activity conveyed information which will assist me in improving the health and/or treatment outcomes of of my patients. - 2	This activity conveyed information which will assist me in improving the health and/or treatment outcomes of of my patients. - 1

How confident are you in your ability to: *

5 = High level of confidence 4 = Moderately high level of confidence 3 = Average level of confidence 2 = Low level of confidence 1 = No level of confidence Not applicable|Not applicable

	5	4	3	2	1	Not applicable
Recognize common cutaneous manifestations of systemic disease.	Recognize common cutaneous manifestations of systemic disease. - 5	Recognize common cutaneous manifestations of systemic disease. - 4	Recognize common cutaneous manifestations of systemic disease. - 3	Recognize common cutaneous manifestations of systemic disease. - 2	Recognize common cutaneous manifestations of systemic disease. - 1	Recognize common cutaneous manifestations of systemic disease. - Not applicable
Introduce and discuss newest migraine management preventives, and when they would be used	Introduce and discuss newest migraine management preventives, and when they would be used - 5	Introduce and discuss newest migraine management preventives, and when they would be used - 4	Introduce and discuss newest migraine management preventives, and when they would be used - 3	Introduce and discuss newest migraine management preventives, and when they would be used - 2	Introduce and discuss newest migraine management preventives, and when they would be used - 1	Introduce and discuss newest migraine management preventives, and when they would be used - Not applicable
Present the dual use of Loop Diuretics and Carbonic Anhydrase inhibitors in Congestive Heart Failure.	Present the dual use of Loop Diuretics and Carbonic Anhydrase inhibitors in Congestive Heart Failure. - 5	Present the dual use of Loop Diuretics and Carbonic Anhydrase inhibitors in Congestive Heart Failure. - 4	Present the dual use of Loop Diuretics and Carbonic Anhydrase inhibitors in Congestive Heart Failure. - 3	Present the dual use of Loop Diuretics and Carbonic Anhydrase inhibitors in Congestive Heart Failure. - 2	Present the dual use of Loop Diuretics and Carbonic Anhydrase inhibitors in Congestive Heart Failure. - 1	Present the dual use of Loop Diuretics and Carbonic Anhydrase inhibitors in Congestive Heart Failure. - Not applicable
Appraise fluid and neuroimaging biomarkers for diagnosis in CTE.	Appraise fluid and neuroimaging biomarkers for diagnosis in CTE. - 5	Appraise fluid and neuroimaging biomarkers for diagnosis in CTE. - 4	Appraise fluid and neuroimaging biomarkers for diagnosis in CTE. - 3	Appraise fluid and neuroimaging biomarkers for diagnosis in CTE. - 2	Appraise fluid and neuroimaging biomarkers for diagnosis in CTE. - 1	Appraise fluid and neuroimaging biomarkers for diagnosis in CTE. - Not applicable
Technology and techniques available to the provider for prostate cancer screening.	Technology and techniques available to the provider for prostate cancer screening. - 5	Technology and techniques available to the provider for prostate cancer screening. - 4	Technology and techniques available to the provider for prostate cancer screening. - 3	Technology and techniques available to the provider for prostate cancer screening. - 2	Technology and techniques available to the provider for prostate cancer screening. - 1	Technology and techniques available to the provider for prostate cancer screening. - Not applicable

How satisfied or dissatisfied were you with the Speaker's effectiveness in addressing the learning objectives? *

Scoring Key: 5=Strongly satisfied 4= Somewhat satisfied 3=Neither satisfied nor dissatisfied 2= Somewhat dissatisfied 1=Strongly dissatisfied NA= Not Applicable

	5	4	3	2	1	NA
Nephrology Year in Review 2022: Top Articles and Trial Results - Warren L. Kupin, M.D., FACP	Nephrology Year in Review 2022: Top Articles and Trial Results - Warren L. Kupin, M.D., FACP - 5	Nephrology Year in Review 2022: Top Articles and Trial Results - Warren L. Kupin, M.D., FACP - 4	Nephrology Year in Review 2022: Top Articles and Trial Results - Warren L. Kupin, M.D., FACP - 3	Nephrology Year in Review 2022: Top Articles and Trial Results - Warren L. Kupin, M.D., FACP - 2	Nephrology Year in Review 2022: Top Articles and Trial Results - Warren L. Kupin, M.D., FACP - 1	Nephrology Year in Review 2022: Top Articles and Trial Results - Warren L. Kupin, M.D., FACP - NA
The Lost Art of Uroscopy: Urine Color as a Diagnostic Tool - Warren L. Kupin, M.D., FACP	The Lost Art of Uroscopy: Urine Color as a Diagnostic Tool - Warren L. Kupin, M.D., FACP - 5	The Lost Art of Uroscopy: Urine Color as a Diagnostic Tool - Warren L. Kupin, M.D., FACP - 4	The Lost Art of Uroscopy: Urine Color as a Diagnostic Tool - Warren L. Kupin, M.D., FACP - 3	The Lost Art of Uroscopy: Urine Color as a Diagnostic Tool - Warren L. Kupin, M.D., FACP - 2	The Lost Art of Uroscopy: Urine Color as a Diagnostic Tool - Warren L. Kupin, M.D., FACP - 1	The Lost Art of Uroscopy: Urine Color as a Diagnostic Tool - Warren L. Kupin, M.D., FACP - NA
Modern Day Screening for Prostate Cancer - David Thiel, M.D.	Modern Day Screening for Prostate Cancer - David Thiel, M.D. - 5	Modern Day Screening for Prostate Cancer - David Thiel, M.D. - 4	Modern Day Screening for Prostate Cancer - David Thiel, M.D. - 3	Modern Day Screening for Prostate Cancer - David Thiel, M.D. - 2	Modern Day Screening for Prostate Cancer - David Thiel, M.D. - 1	Modern Day Screening for Prostate Cancer - David Thiel, M.D. - NA
Dermatologic Manifestations of Systemic Disease - Scott Andrew Elman, M.D.	Dermatologic Manifestations of Systemic Disease - Scott Andrew Elman, M.D. - 5	Dermatologic Manifestations of Systemic Disease - Scott Andrew Elman, M.D. - 4	Dermatologic Manifestations of Systemic Disease - Scott Andrew Elman, M.D. - 3	Dermatologic Manifestations of Systemic Disease - Scott Andrew Elman, M.D. - 2	Dermatologic Manifestations of Systemic Disease - Scott Andrew Elman, M.D. - 1	Dermatologic Manifestations of Systemic Disease - Scott Andrew Elman, M.D. - NA
Updates in Chronic Traumatic Encephalopathy (CTE) - Amaal J. Starling, MD, FAHS, FAAN	Updates in Chronic Traumatic Encephalopathy (CTE) - Amaal J. Starling, MD, FAHS, FAAN - 5	Updates in Chronic Traumatic Encephalopathy (CTE) - Amaal J. Starling, MD, FAHS, FAAN - 4	Updates in Chronic Traumatic Encephalopathy (CTE) - Amaal J. Starling, MD, FAHS, FAAN - 3	Updates in Chronic Traumatic Encephalopathy (CTE) - Amaal J. Starling, MD, FAHS, FAAN - 2	Updates in Chronic Traumatic Encephalopathy (CTE) - Amaal J. Starling, MD, FAHS, FAAN - 1	Updates in Chronic Traumatic Encephalopathy (CTE) - Amaal J. Starling, MD, FAHS, FAAN - NA
Update in Migraine Headache Management - Olga Fermo, M.D.	Update in Migraine Headache Management - Olga Fermo, M.D. - 5	Update in Migraine Headache Management - Olga Fermo, M.D. - 4	Update in Migraine Headache Management - Olga Fermo, M.D. - 3	Update in Migraine Headache Management - Olga Fermo, M.D. - 2	Update in Migraine Headache Management - Olga Fermo, M.D. - 1	Update in Migraine Headache Management - Olga Fermo, M.D. - NA
Emerging and Re-Emerging Diseases – Monkeypox, Ebola, and What May be Next - Larry M. Bush, M.D., FACP, FIDSA	Emerging and Re-Emerging Diseases – Monkeypox, Ebola, and What May be Next - Larry M. Bush, M.D., FACP, FIDSA - 5	Emerging and Re-Emerging Diseases – Monkeypox, Ebola, and What May be Next - Larry M. Bush, M.D., FACP, FIDSA - 4	Emerging and Re-Emerging Diseases – Monkeypox, Ebola, and What May be Next - Larry M. Bush, M.D., FACP, FIDSA - 3	Emerging and Re-Emerging Diseases – Monkeypox, Ebola, and What May be Next - Larry M. Bush, M.D., FACP, FIDSA - 2	Emerging and Re-Emerging Diseases – Monkeypox, Ebola, and What May be Next - Larry M. Bush, M.D., FACP, FIDSA - 1	Emerging and Re-Emerging Diseases – Monkeypox, Ebola, and What May be Next - Larry M. Bush, M.D., FACP, FIDSA - NA

Was this course fair, balanced and without commercial bias? *

Yes

No

If you checked "No,” please explain why: *

As a result of my participation in this Symposium, I commit to make the following changes to my clinical practice: *

Iwill recognize common cutaneous manifestations of systemic disease.

I will Introduce and discuss newest migraine management preventives, and when they would be used.

I will present the dual use of Loop Diuretics and Carbonic Anhydrase inhibitors in Congestive Heart Failure.

I will appraise fluid and neuroimaging biomarkers for diagnosis in CTE.

I will utilize technology and techniques available to the provider for prostate cancer screening.

Not applicable to my practice.

I do not agree with the recommendations presented.

I am retired.

What, if any, new skills/strategies will you apply in your clinical practice? *

What are the potential barriers or obstacles that might prevent you from implementing new strategies you learned at this activity? *

Comments

Name

Attestation *

Choose 1 option

I attest that I have participated in this live virtual symposium in its entirety.

I attest that I have participated in _____ hours of instruction during this live webinar.

hours attestation *

Hours attended

You are here

2023 Boca Raton Regional Hospital Internal Medicine Symposium Evaluation - Day 3